ĐÁNH GIÁ KHẢ NĂNG TIẾP CẬN DỊCH VỤ Y TẾ CỦA BỆNH NHÂN MẮC BỆNH MÃN TÍNH TRONG THỜI KỲ GIÃN CÁCH XÃ HỘI DO DỊCH COVID-19

Abstract

A cross-sectional study was conducted on 299 patients with NCDs through quota sampling from January to July 2021 to assess the accessibility of medical services of NCDs patients during the period of social distancing due to the COVID-19 pandemic and identify its related factors. Pre-design questionnaires are used to assess the patient's ability to access health services. In total, 299 patients participated in the study, 47.2% did not have access to medical services with the main barriers including difficulty finding public transport to frequently used healthcare facilities (20.7%), difficulty due to the limited number of patients examined by health facilities (21.7%), Facing difficulties due to the health workers in charge of medical examination and treatment having to take on the tasks of preventing/fighting against COVID-19 (30.4%). Multivariable logistic regression model showed that educational level (OR=3.11, 95%KTC 1.50-6.45, p=0.002), distance to medical facilities (OR=1.1.95) %CI 1.05-1.14; p = 0.01), fear of the impact of COVID on health (OR = 1.15, 95% CI 1.01-1.32; p = 0.03) were associated with the patient's lack of access to medical services

https://doi.org/10.26459/hueunijssh.v131i6A.6517
PDF

References

  1. Worldometers (2020) COVID-19 CORONAVIRUS PANDEMIC [Available from: https://www.worldometers.info/coronavirus/], accessed 15/7/2021
  2. Kluge HHP, Wickramasinghe K, Rippin HL, Mendes R, Peters DH, Kontsevaya A, et al (2020), Prevention and control of non-communicable diseases in the COVID-19 response, The Lancet, 395(10238), pp.1678-1680.
  3. Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al (2020), Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab, 31(6), pp. 1068-77.e3.
  4. Peçanha T, Goessler KF, Roschel H, Gualano B (2020), Social isolation during the COVID-19 pandemic can increase physical inactivity and the global burden of cardiovascular disease, Am J Physiol Heart Circ Physiol, 318(6), pp.H1441-h6.
  5. Roschel H, Artioli GG, Gualano B (2020), Risk of Increased Physical Inactivity During COVID-19 Outbreak in Older People: A Call for Actions, J Am Geriatr Soc, 68(6), pp.1126-1128.
  6. Barone MTU, Harnik SB, de Luca PV, Lima BLS, Wieselberg RJP, Ngongo B, et al (2020), The impact of COVID-19 on people with diabetes in Brazil, Diabetes Res Clin Pract, 166:108304.
  7. Górnicka M, Drywień ME, Zielinska MA, Hamułka J (2020), Dietary and Lifestyle Changes During COVID-19 and the Subsequent Lockdowns among Polish Adults: A Cross-Sectional Online Survey PLifeCOVID-19 Study, Nutrients, 12(8).
  8. WHO. Food and Nutrition during Self-Quarantine: What to Choose and How to Eat Healthy 2020 [Available from: http://www.euro.who.int/en/health-topics/disease prevention/nutrition/news/news/2020/3/food-and-nutrition-during-self-quarantine-what-to-choose-and-how-to-eat-healthily.], accessed 15/7/2021
  9. BDA (2021), Eating Well during Coronavirus/COVID-19, [Available from: https://www.bda.uk.com/resource/eating-well-during-coronavirus-covid-19.html.], accessed 15/7/2021
  10. Rauber F, da Costa Louzada ML, Steele EM, Millett C, Monteiro CA, Levy RB (2018), Ultra-Processed Food Consumption and Chronic Non-Communicable Diseases-Related Dietary Nutrient Profile in the UK (2008⁻2014), Nutrients, 10(5).
  11. Abdela SG, Berhanu AB, Ferede LM, van Griensven J (2020), Essential Healthcare Services in the Face of COVID-19 Prevention: Experiences from a Referral Hospital in Ethiopia, Am J Trop Med Hyg. 103(3), pp.1198-200.
  12. Aledo-Serrano Á, Mingorance A, Jiménez-Huete A, Toledano R, García-Morales I, Anciones C, et al (2018), Genetic epilepsies and COVID-19 pandemic: Lessons from the caregiver perspective, Epilepsia, 61(6), pp.1312-4.
  13. Dopfer C, Wetzke M, Zychlinsky Scharff A, Mueller F, Dressler F, Baumann U, et al (2020), COVID-19 related reduction in pediatric emergency healthcare utilization - a concerning trend., BMC Pediatr, 20(1), pp.427.
  14. Goldenberg MM (2010), Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment, P t, 35(7), pp.392-415.
  15. Nshimyiryo A, Barnhart DA, Cubaka VK, Dusengimana JMV, Dusabeyezu S, Ndagijimana D, et al (2021), Barriers and coping mechanisms to accessing healthcare during the COVID-19 lockdown: a cross-sectional survey among patients with chronic diseases in rural Rwanda, BMC Public Health, 21(1), pp.704.
  16. Leite JS, Feter N, Caputo EL, Doring IR, Cassuriaga J, Reichert FF, et al (2021), Managing noncommunicable diseases during the COVID-19 pandemic in Brazil: findings from the PAMPA cohort, Cien Saude Colet, 26(3), pp.987-1000.
  17. Abera Abaerei A, Ncayiyana J, Levin J (2017), Health-care utilization and associated factors in Gauteng province, South Africa, Glob Health Action, 10(1):1305765.
  18. Ahmed S, Ajisola M, Azeem K, Bakibinga P, Chen YF, Choudhury NN, et al (2020), Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements. BMJ Glob Health, 5(8).
  19. Lau LS, Samari G, Moresky RT, Casey SE, Kachur SP, Roberts LF, et al (2020), COVID-19 in humanitarian settings and lessons learned from past epidemics, Nat Med, 26(5), pp. 647-8.